Rehan “Ray” Zuberi, who formerly operated the Diagnostic Imaging Affiliates network of imaging centers now embroiled in a massive kickback scandal in New Jersey, has admitted guilt along with his wife, Humara Paracha, for their part in the scheme to buy referrals and falsify records to increase reimbursement.

A Wayne County, Mich., jury has awarded $21 million to the family of Bimla Nayyar, who died in 2012 after a brain surgery that wasn’t supposed to be performed.

The trial for a much anticipated antitrust case brought against Alliance Radiology by former employee and prominent radiologist Mark Idstrom began last week in Johnson County District Court.

Responding to risks in healthcare is tricky business, and more often than not leads to lengthy and sometimes heated debate. This week’s top story, on the continuing developments in the study of gadolinium contrast retention, offers another such dilemma.

The American Roentgen Ray Society (ARRS) has a new president. Jonathan S. Lewin, MD, senior vice president for integrated health care delivery and co-chair for strategic planning at Johns Hopkins Medicine was elected to the position at the ARRS 2015 Annual Meeting held last month in Toronto.

Researchers studying variations in cost for outpatient knee MRI examinations found dramatic differences in price on both national and local levels, with reduced prices in areas with a higher populations. The results of the study were published in the May issue of the Journal of the American College of Radiology.

As more research suggests gadolinium-based contrast agents (GBCAs) may remain in the brain for years after a contrast MRI, an editorial in Radiology has called for radiologists to rethink the appropriate use and indications of these agents while more studies are conducted to assess the long-term clinical effect, if any, of lingering gadolinium retention.

Numerous studies showing evidence of gadolinium retention in the brains of MRI contrast patients are building momentum for an industry-wide reassessment of the current usage of gadolinium-based contrast agents. Emanuel Kanal, MD, a nationally recognized leader in the area of MRI safety, spoke with Health Imaging for an exclusive interview regarding this new evidence of gadolinium retention and its potential impact on diagnostic imaging and patient safety.